HealthEquity, Inc. (NASDAQ:HQY) Shares Purchased by Peterson Wealth Services

Peterson Wealth Services lifted its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 5.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,507 shares of the company’s stock after purchasing an additional 509 shares during the quarter. Peterson Wealth Services’ holdings in HealthEquity were worth $1,008,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. Paladin Wealth LLC acquired a new stake in HealthEquity in the third quarter worth approximately $39,000. UMB Bank n.a. grew its holdings in HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after acquiring an additional 164 shares during the period. GAMMA Investing LLC grew its holdings in HealthEquity by 57.8% during the third quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock worth $77,000 after acquiring an additional 344 shares during the period. Quarry LP raised its position in HealthEquity by 418.8% in the third quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after acquiring an additional 1,089 shares in the last quarter. Finally, 1620 Investment Advisors Inc. acquired a new stake in HealthEquity in the 3rd quarter valued at about $112,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

HQY stock opened at $112.15 on Tuesday. The firm has a 50 day simple moving average of $101.18 and a 200 day simple moving average of $89.98. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $113.61. The stock has a market cap of $9.72 billion, a P/E ratio of 102.89, a P/E/G ratio of 1.61 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the previous year, the firm earned $0.40 EPS. Research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In other news, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at $1,843,579.92. This represents a 56.74 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the completion of the sale, the director now directly owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. The trade was a 11.04 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently commented on HQY. Royal Bank of Canada boosted their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Mizuho initiated coverage on HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target on the stock. The Goldman Sachs Group assumed coverage on HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective for the company. Barrington Research boosted their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, December 2nd. Finally, JMP Securities increased their price target on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $110.71.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.